Rectal cancer (staging)

Staging strongly influences the success of and rate of local recurrence following rectal cancer resection. MRI is the modality of choice for the staging of rectal cancer, to guide surgical and non-surgical management options. MRI is used at diagnosis, following downstaging chemoradiotherapy, and in follow-up, if a non-operative approach is used.

TNM staging

See: TNM staging system for a general description.

Primary tumour staging (T)

Strictly speaking TNM staging, such as the American Joint Committee on Cancer (AJCC) 8th edition, does not subclassify T3. However, this subclassification does have treatment and prognostic significance 7,8

  • Tx: primary tumour cannot be assessed
  • T0: no evidence of primary tumour
  • Tis: carcinoma in situ: intraepithelial or invasion of lamina propria
  • T1: tumour invades submucosa
  • T2: tumour invades muscularis propria
  • T3: tumour invades through the muscularis propria into the subserosa or into non-peritonealised perirectal tissues
    • T3a: tumour extends <1 mm beyond muscularis propria 4
    • T3b: tumour extends 1-5 mm beyond muscularis propria 4
    • T3c: tumour extends 5-15 mm beyond muscularis propria 4
    • T3d: tumour extends 15 mm beyond muscularis propria 4
  • T4: tumour invades directly into other organs or structures and/or perforates visceral peritoneum
    • T4a: tumour penetrates to the surface of the visceral peritoneum
    • T4b: tumour directly invades or is adherent to other organs or structures
Regional lymph nodes (N)

Signal heteroegenity and irregular contour are the most reliable signs of nodal involvement on MRI.

  • Nx: regional nodes cannot be assessed
  • N0: no regional lymph node metastases
  • N1: metastasis in 1-3 regional (perirectal) lymph nodes
    • N1a: metastasis in 1 regional lymph node
    • N1b: metastasis in 2-3 regional lymph nodes
    • N1c: tumour deposit(s) in the subserosa, mesentery, or non-peritonealised pericolic or perirectal tissues without regional nodal metastasis
  • N2: metastasis in 4 or more regional lymph nodes
    • N2a: metastasis in 4-6 regional lymph nodes
    • N2b: metastasis in 7 or more regional lymph nodes
Metastases (M)
  • Mx: cannot be assessed
  • M0: no distant metastasis
  • M1: distant metastasis
    • M1a: metastasis confined to one organ or site (for example, liver, lung, ovary, non-regional node)
    • M1b: metastases in more than one organ/site or the peritoneum
Stage groupings
  • stage 0: Tis N0 M0
  • stage I: T1-2, N0 M0
  • stage II
    • IIa: T3, N0, M0
    • IIb: T4a, N0, M0
    • IIc: T4b, N0, M0
  • stage III
    • IIIa: T1-2, N1, M0
    • IIIb: T3-4, N1, M0
    • IIIc: T3-4b, N2, M0
  • stage IV: any T, any N, M1
Additional prognostic indicators

The following are significant prognostic indicators, and should be commented on when staging rectal cancer with MRI, alongside the TNM stage:

  • extramural venous invasion (EMVI)
    • may be contiguous or non-contiguous
    • non-contiguous deposits reflect N1c
    • imparts poor prognosis as a predictor of haematogenous spread
  • circumferential resection margin (CRM)
    • represented by the mesorectal fascia (MRF)
    • CRM positive if either tumour, involved lymph node, or EMVI (continuous or discontinuous) is within 1 mm of the mesorectal fascia
    • peritoneal reflection does not constitute CRM, which if involved reflects at least stage T4a disease
Additional specific MRI imaging staging subsets of rectal tumour

Special consideration should be given to low rectal tumours as these carry a different prognosis from higher lesions. This is predominantly due to anatomical considerations including waist-like tapering of the mesorectum 10

Early rectal cancer and significant polyps may also be subclassified, necessitating the use of good quality, high-resolution T2-weighted MR images. This relies on the recognition that most rectal tumours (apart from mucinous tumours) have intermediate T2 signal compared to hyperintense submucosa and hypointense muscularis layers 9. Such staging may be helpful in selecting less extensive surgical resection options.

  • Low rectal tumour staging 10
    • Stage 1: tumour confined to bowel wall with intact outer muscularis propria
    • Stage 2: tumour replaces muscularis propria but does not extend into intersphincteric plane
    • Stage 3: tumour invades intersphincteric plane or lies within 1 mm of levator muscles
    • Stage 4: tumour invades external anal sphincter and is within 1 mm and beyond levators with or without invading adjacent organs
  • Early rectal tumour staging 9
    • T0/early T1sm1: no submucosa (sm) disruption evident with entire thickness of submucosal stripe preserved
    • T1sm2: at least 1 mm of submucosa preserved
    • T1sm3/early T2: less than 1 mm of submucosa preserved but full thickness of muscularis propria preserved
    • T2 early: more than 1 mm muscularis propria preserved
    • T2/T3a: 0 mm muscularis propria preserved / less than 1 mm microscopic invasion beyond muscularis propria (prognosis identical)
    • T3b: 1-5 mm invasion beyond muscularis propria (still carries good prognosis)

See also

Share article

Article information

rID: 7136
Section: Staging
Synonyms or Alternate Spellings:
  • Rectal Cancer Staging TNM
  • Staging of rectal cancer
  • Staging of rectal cancers

Support Radiopaedia and see fewer ads

Cases and figures

  • Drag
    Rectal cancer T1
    Case 1: T3N2
    Drag here to reorder.
  • Drag
    Case 2: T3N2
    Drag here to reorder.
  • Drag
    Rectal cancer T2
    Case 3: T3N2
    Drag here to reorder.
  • Drag
    Case 4: T3N1
    Drag here to reorder.
  • Drag
    Case 5: T4 tumour with prostatic invasion
    Drag here to reorder.
  • Drag
    Case 6: T3N0
    Drag here to reorder.
  • Updating… Please wait.

    Alert accept

    Error Unable to process the form. Check for errors and try again.

    Alert accept Thank you for updating your details.